2008: 100/1 (July) pp. 1-171

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

36 articles
1.
Thrombosis and Haemostasis: Volume 100 and going strong ….

Klaus T. Preissner1, Gregory Y. H. Lip2

1Department of Biochemistry, Medical School, Justus-Liebig-University,Giessen, Germany; 2Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

Thrombosis and Haemostasis 2008 100 1: 1-2

http://dx.doi.org/10.1160/TH08-06-0359

[Summary] [Free download]
2.
Mean platelet volume not so far from being a routine diagnostic and prognostic measurement

Ertan Yetkin

Department of Cardiology, International Medical Center, Mersin, Turkey

Thrombosis and Haemostasis 2008 100 1: 3-4

http://dx.doi.org/10.1160/TH08-05-0336

[Summary] [Free download]
3.
Newly diagnosed venous thromboembolism: Which patients will bleed after anticoagulation is initiated?

Samuel Z. Goldhaber

Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2008 100 1: 5-6

http://dx.doi.org/10.1160/TH08-05-0297

[Summary] [Free download]
4.
Beyond glucose levels in diabetic patients with coronary artery disease: Platelet activity and non-responsiveness to antiplatelet therapy

Eduard Shantsila, Gregory Y. H. Lip

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

Thrombosis and Haemostasis 2008 100 1: 7-8

http://dx.doi.org/10.1160/TH08-06-0342

[Summary] [Free download]
5.
The hidden sepsis marker: aPTT waveform analysis

Carl-Erik Dempfle, Martin Borggrefe

University Hospital of Mannheim, I. Department of Medicine, Mannheim, Germany

Thrombosis and Haemostasis 2008 100 1: 9-10

http://dx.doi.org/10.1160/TH08-05-0308

[Summary] [Free download]
6.
[Add to basket]
Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis

Gregory Y. H. Lip

Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK

Thrombosis and Haemostasis 2008 100 1: 11-13

http://dx.doi.org/10.1160/TH08-05-0331

[Summary] [PDF] [Pay per view]
7.
[Add to basket]
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation' - Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation

Jonathan W. Mant

Primary Care Clinical Sciences, University of Birmingham, Birmingham, UK

Thrombosis and Haemostasis 2008 100 1: 14-15

http://dx.doi.org/10.1160/TH08-06-0344

[Summary] [PDF] [Pay per view]
8.
[Add to basket]
Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation' - Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation

Elaine M. Hylek

Research Unit-Section of General Internal Medicine and Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2008 100 1: 16-17

http://dx.doi.org/10.1160/TH08-06-0343

[Summary] [PDF] [Pay per view]
9.
[Add to basket]
Possible mechanisms contributing to oxidative inactivation of activated protein C: Molecular dynamics study

Armen Nalian, Alexei V. Iakhiaev

1Department of Biotechnology, Stephen F. Austin State University, Nacogdoches, Texas, USA; 2Texas College, Tyler, Texas, USA

Thrombosis and Haemostasis 2008 100 1: 18-25

http://dx.doi.org/10.1160/TH07-12-0750

[Summary] [PDF] [Pay per view]
10.
[Add to basket]
Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry

Nuria Ruíz-Giménez1, Carmen Suárez1, Rocío González2, José Antonio Nieto3, José Antonio Todolí4, Ángel Luis Samperiz5, Manuel Monreal6, and the RIETE Investigators*

1Servicio de Medicina Interna, Hospital de la Princesa, Madrid, Spain; 2Fundación de Investigación Biomédica, Hospital de la Princesa, Madrid, Spain; 3Servicio de Medicina Interna, Hospital Virgen de la Luz, Cuenca, Spain; 4Servicio de Medicina Interna, Hospital Universitario La Fe, Valencia, Spain; 5Servicio de Medicina Interna, Hospital Reina Sofia de Tudela, Navarra, Spain; 6Servicio de Medicina Interna, Hospital Germans Trias i Pujol, Badalona, Spain

Thrombosis and Haemostasis 2008 100 1: 26-31

http://dx.doi.org/10.1160/TH08-03-0193

[Summary] [PDF] [Pay per view]
11.
[Add to basket]
An observational study of sucrose-formulated recombinant factor VIII for Japanese patients with haemophilia A

Jean-Christophe Delumeau1, Chiho Ikegawa1, Chisato Yokoyama1, Verena Haupt2

1Bayer Yakuhin Ltd., Osaka, Japan; 2Bayer Vital, Leverkusen, Germany

Thrombosis and Haemostasis 2008 100 1: 32-37

http://dx.doi.org/10.1160/TH07-12-0724

[Summary] [PDF] [Pay per view]
12.
[Add to basket]
Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombinactivatable fibrinolysis inhibitor (TAFI) levels

Nienke Folkeringa1, Michiel Coppens2, Nic J. G. M. Veeger1, Victor J. J. Bom3, Saskia Middeldorp2, Karly Hamulyak4, Martin H. Prins5, Harry R. Büller2, Jan van der Meer1

1Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Center Groningen, The Netherlands; 2Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; 3Department of Pathology and Laboratory Medicine, University Medical Center Groningen, The Netherlands; 4Department of Hematology, University Hospital Maastricht, The Netherlands; 5Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, The Netherlands

Thrombosis and Haemostasis 2008 100 1: 38-44

http://dx.doi.org/10.1160/TH07-11-0659

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1

Alan T. Nurden1, Paquita Nurden1, Emilsé Bermejo1, Robert Combrié1, Daniel W. McVicar2, A. Valance Washington2,3

1Centre de Référence des Pathologies Plaquettaires, Hôpital Xavier Arnozan, Pessac, France; 2Cancer and Inflammation Program, National Cancer Institute, Frederick, USA; 3Department of Anatomy and Cell Biology, Universidad Central del Caribe, Bayamon, Puerto Rico

Thrombosis and Haemostasis 2008 100 1: 45-51

http://dx.doi.org/10.1160/TH08-02-0067

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
Salsolinol, an endogenous neurotoxin, enhances platelet aggregation and thrombus formation

Ok-Nam Bae*1, Young-Dae Kim*1, Kyung-Min Lim1,2, Ji-Yoon Noh1, Seung-Min Chung1, Keunyoung Kim1, Suyoung Hong1, Sue Shin3, Jong-Hyun Yoon3, Jin-Ho Chung1

1College of Pharmacy, Seoul National University, Seoul, Korea; 2AMOREPACIFIC CO/R&D Center, Gyeonggi-do, Korea; 3Department of Laboratory Medicine, Boramae Hospital, Boramae, Korea

Thrombosis and Haemostasis 2008 100 1: 52-59

http://dx.doi.org/10.1160/TH07-08-0529

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Effects of von Willebrand factor concentration and platelet collision on shear-induced platelet activation

Zhenyue Gao1, Fang Liu2, Ziqiang Yu2, Xia Bai2, Chun Yang1, Fengyuan Zhuang1, Changgeng Ruan2

1Bioengineering Department of Beijing University of Aeronautics and Astronautics, Beijing, China; 2Jiangsu Institute of Hematology, Suzhou, China

Thrombosis and Haemostasis 2008 100 1: 60-68

http://dx.doi.org/10.1160/TH07-03-0222

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid

Nick Clappers1, Martijn G. H. van Oijen2, Santosh Sundaresan3, Marc A. Brouwer1, Rene H. M. te Morsche2, Wessel Keuper1, Wilbert H. M. Peters2, Joost P. H. Drenth2, Freek W. A. Verheugt1

1Radboud University Medical Centre, Department of Cardiology; 2Department of Gastro-enterology; Nijmegen, The Netherlands; 3Christian Medical College and Hospital, Department of Gastrointestinal Sciences, Vellore, India

Thrombosis and Haemostasis 2008 100 1: 70-75

http://dx.doi.org/10.1160/TH08-03-0172

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease

Victor Serebruany1, Ilya Pokov1, Wiktor Kuliczkowski2, James Chesebro3, Juan Badimon4

1HeartDrug™ Research Laboratories, Johns Hopkins University, Towson, Maryland, USA; 2Silesian Center for Heart Diseases, Zabrze, Poland; 3University of Massachusetts, Worcester, Massachusetts, USA; 4Mount Sinai School of Medicine, New York, New York, USA

Thrombosis and Haemostasis 2008 100 1: 76-82

http://dx.doi.org/10.1160/TH08-03-0136

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
Increased platelet sensitivity among individuals with aspirin resistance – Platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy

Sasidhar Guthikonda1, Kirankumar Mangalpally1, Muthiah Vaduganathan1, Rajnikant Patel2, Timothy DeLao1, Angela L. Bergeron3, Jing-Fei Dong3, Eli I. Lev1, Neal S. Kleiman1

1The Methodist Hospital Research Institute and The Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA; 2Department of Cardiology, Sun Health Boswell Hospital, Boswell, Arizona, USA; 3Department of Thrombosis, Baylor College of Medicine, Houston, Texas, USA

Thrombosis and Haemostasis 2008 100 1: 83-89

http://dx.doi.org/10.1160/TH07-10-0590

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency

Online Supplementary Material

Nelson E. Bruno1, Yutaka Yano1, Yoshiyuki Takei3, Liqiang Qin4, Toshinari Suzuki1, John Morser4,7, Corina N. D’Alessandro-Gabazza2, Akira Mizoguchi6, Koji Suzuki5, Osamu Taguchi2, Esteban C. Gabazza4, Yasuhiro Sumida1

1Department of Diabetes and Endocrinology, 2Department of Pulmonary and CriticalCare Medicine, 3Department of Gastroenterology and Hepatology, 4Department of Immunology, 5Department of Molecular Pathobiology, 6Department of Neural Regeneration and Cell Communication, Mie University Graduate School of Medicine, Tsu-city, Mie, Japan; 7Department of Cardiovascular Research, Berlex Biosciences, Richmond, California, USA

Thrombosis and Haemostasis 2008 100 1: 90-100

http://dx.doi.org/10.1160/TH08-02-0092

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand

Jong-Sup Bae, Alireza R. Rezaie

Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, USA

Thrombosis and Haemostasis 2008 100 1: 101-109

http://dx.doi.org/10.1160/TH08-02-0127

[Summary] [PDF] [Pay per view]
  1-20 21-36
Next page

Articles

You've 330 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...